Per- and polyfluoroalkyl substances (PFASs) modify lung surfactant function and pro-inflammatory responses in human bronchial epithelial cells.

[1]  M. Longnecker,et al.  Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian Mother and Child (MoBa) cohort. , 2019, Environment international.

[2]  J. Pérez-Gil,et al.  Understanding the principle biophysics concepts of pulmonary surfactant in health and disease , 2018, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[3]  Heather M. Wallace,et al.  Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food , 2018, EFSA journal. European Food Safety Authority.

[4]  K. Hougaard,et al.  Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects , 2018, International journal of pharmaceutics.

[5]  T. Sosnowski.  Particles on the lung surface - physicochemical and hydrodynamic effects , 2018, Current Opinion in Colloid & Interface Science.

[6]  J. Sørli,et al.  Animal Testing for Acute Inhalation Toxicity: A Thing of the Past? , 2018, Applied In Vitro Toxicology.

[7]  Lijie Grace Zhang,et al.  Biophysical Assessment of Pulmonary Surfactant Predicts the Lung Toxicity of Nanomaterials , 2018 .

[8]  Peder Wolkoff,et al.  Pulmonary injury associated with spray of a water-based nano-sized waterproofing product: a case study , 2017, Journal of Occupational Medicine and Toxicology.

[9]  E. Papadopoulou,et al.  Investigation of the Best Approach for Assessing Human Exposure to Poly- and Perfluoroalkyl Substances through Indoor Air. , 2017, Environmental science & technology.

[10]  T. Church,et al.  Per‐ and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000–2015 , 2017, Environmental research.

[11]  Y. Li,et al.  Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water , 2017, Occupational and Environmental Medicine.

[12]  S. Rigdon,et al.  Association of perfluoroalkyl substances exposure with impaired lung function in children , 2017, Environmental research.

[13]  Mingyong Han,et al.  Perfluorodecanoic acid stimulates NLRP3 inflammasome assembly in gastric cells , 2017, Scientific Reports.

[14]  Zhanyun Wang,et al.  A Never-Ending Story of Per- and Polyfluoroalkyl Substances (PFASs)? , 2017, Environmental science & technology.

[15]  E. Budtz-Jørgensen,et al.  Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years , 2017, Journal of immunotoxicology.

[16]  T. K. Jensen,et al.  Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4years among 359 children in the Odense Child Cohort. , 2016, Environment international.

[17]  Jinlong Yang,et al.  Automated Droplet Manipulation Using Closed-Loop Axisymmetric Drop Shape Analysis. , 2016, Langmuir : the ACS journal of surfaces and colloids.

[18]  Konrad Hungerbühler,et al.  Comparative assessment of the environmental hazards of and exposure to perfluoroalkyl phosphonic and phosphinic acids (PFPAs and PFPiAs): Current knowledge, gaps, challenges and research needs. , 2016, Environment international.

[19]  B. Thomsen,et al.  A Proposed In Vitro Method to Assess Effects of Inhaled Particles on Lung Surfactant Function. , 2016, American journal of respiratory cell and molecular biology.

[20]  Hidehiro Watanabe,et al.  Diffuse alveolar hemorrhage after use of a fluoropolymer-based waterproofing spray , 2015, SpringerPlus.

[21]  R. Ebinghaus,et al.  Neutral Poly/Per-Fluoroalkyl Substances in Air from the Atlantic to the Southern Ocean and in Antarctic Snow. , 2015, Environmental science & technology.

[22]  Y. Zuo,et al.  Biophysical influence of airborne carbon nanomaterials on natural pulmonary surfactant. , 2015, ACS nano.

[23]  G. Gilkeson,et al.  In vitro evaluation of the effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on IL‐2 production in human T‐cells , 2015, Journal of applied toxicology : JAT.

[24]  Sarah L. Doyle,et al.  Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives , 2015, Journal of inflammation research.

[25]  R. Luebke,et al.  Perfluorinated compounds: emerging POPs with potential immunotoxicity. , 2014, Toxicology letters.

[26]  M. Lag,et al.  AhR and Arnt differentially regulate NF-κB signaling and chemokine responses in human bronchial epithelial cells , 2014, Cell Communication and Signaling.

[27]  M. Lag,et al.  Toll like receptor-3 priming alters diesel exhaust particle-induced cytokine responses in human bronchial epithelial cells. , 2014, Toxicology letters.

[28]  R. Hiatt,et al.  Perfluoroalkyl Chemicals and Asthma among Children 12–19 Years of Age: NHANES (1999–2008) , 2014, Environmental health perspectives.

[29]  J. Pérez-Gil,et al.  Structure-function relationships in pulmonary surfactant membranes: from biophysics to therapy. , 2014, Biochimica et biophysica acta.

[30]  Peder Wolkoff,et al.  Pulmonary toxicity following exposure to a tile coating product containing alkylsiloxanes. A clinical and toxicological evaluation , 2014, Clinical toxicology.

[31]  A. Bergman,et al.  Tissue distribution of 35S-labelled perfluorobutanesulfonic acid in adult mice following dietary exposure for 1-5 days. , 2014, Chemosphere.

[32]  L. S. Haug,et al.  Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood , 2013, Journal of immunotoxicology.

[33]  M. Lag,et al.  Mechanisms of chemokine responses by polycyclic aromatic hydrocarbons in bronchial epithelial cells: sensitization through toll-like receptor-3 priming. , 2013, Toxicology letters.

[34]  T. Noah,et al.  Diesel exhaust particles modify natural killer cell function and cytokine release , 2013, Particle and Fibre Toxicology.

[35]  H. Westberg,et al.  Professional ski waxers' exposure to PFAS and aerosol concentrations in gas phase and different particle size fractions. , 2013, Environmental science. Processes & impacts.

[36]  Sang-Hyun Kim,et al.  Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators. , 2012, Toxicology letters.

[37]  Marina Marinovich,et al.  In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). , 2012, Toxicology and applied pharmacology.

[38]  A. Bergman,et al.  Tissue distribution of ³⁵S-labelled perfluorooctane sulfonate in adult mice after oral exposure to a low environmentally relevant dose or a high experimental dose. , 2011, Toxicology.

[39]  L. S. Haug,et al.  Characterisation of human exposure pathways to perfluorinated compounds--comparing exposure estimates with biomarkers of exposure. , 2011, Environment International.

[40]  Y. Fukui,et al.  [Diffuse alveolar hemorrhage arising after use of a waterproofing spray]. , 2011, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[41]  Martin Schlabach,et al.  Investigation on per- and polyfluorinated compounds in paired samples of house dust and indoor air from Norwegian homes. , 2011, Environmental science & technology.

[42]  Marina Marinovich,et al.  In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs). , 2011, Toxicology and applied pharmacology.

[43]  A. Bergman,et al.  Tissue distribution of (35)S-labelled perfluorooctane sulfonate (PFOS) in C57Bl/6 mice following late gestational exposure. , 2010, Reproductive toxicology.

[44]  L. S. Haug,et al.  Occupational exposure to airborne perfluorinated compounds during professional ski waxing. , 2010, Environmental science & technology.

[45]  J. Pérez-Gil,et al.  Pulmonary surfactant pathophysiology: current models and open questions. , 2010, Physiology.

[46]  H. Lehmler,et al.  Model and cell membrane partitioning of perfluorooctanesulfonate is independent of the lipid chain length. , 2010, Colloids and surfaces. B, Biointerfaces.

[47]  Hans-Joachim Lehmler,et al.  Partitioning of perfluorooctanoate into phosphatidylcholine bilayers is chain length-independent. , 2010, Chemistry and physics of lipids.

[48]  I. Khalid,et al.  Open Access Journal of Medical Case Reports Chemical Pneumonitis and Subsequent Reactive Airways Dysfunction Syndrome after a Single Exposure to a Household Product: a Case Report , 2009 .

[49]  Cathrine Thomsen,et al.  Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. , 2009, Environmental science & technology.

[50]  A. Neumann,et al.  Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation. , 2008, Biochimica et biophysica acta.

[51]  V. Sill,et al.  [Alveolitis after inhalation of leather-impregnation spray (author's transl)]. , 2008, Deutsche medizinische Wochenschrift.

[52]  P. Bummer,et al.  Effect of potassium perfluorooctanesulfonate, perfluorooctanoate and octanesulfonate on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayers. , 2007, Biochimica et biophysica acta.

[53]  L. Shaw,et al.  Community Exposure to Perfluorooctanoate: Relationships Between Serum Concentrations and Exposure Sources , 2006, Journal of occupational and environmental medicine.

[54]  L. Shaw,et al.  Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health Parameters , 2006, Journal of occupational and environmental medicine.

[55]  C. Lau,et al.  Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[56]  C. Lau,et al.  Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. , 2005, Birth defects research. Part B, Developmental and reproductive toxicology.

[57]  J. Zasadzinski,et al.  Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental. , 2005, Biophysical journal.

[58]  P. H. Brown,et al.  Horse rug lung: toxic pneumonitis due to fluorocarbon inhalation , 2005, Occupational and Environmental Medicine.

[59]  F. Sarmiento,et al.  The aggregation of sodium perfluorooctanoate in water , 2005 .

[60]  Kouji Harada,et al.  Effects of PFOS and PFOA on L-type Ca2+ currents in guinea-pig ventricular myocytes. , 2005, Biochemical and biophysical research communications.

[61]  M. Stanton,et al.  Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[62]  R. Spragg,et al.  Lung surfactant in subacute pulmonary disease , 2002, Respiratory research.

[63]  H. Tanaka,et al.  [Acute respiratory failure due to inhalation of aerosol water proof agent]. , 2000, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[64]  R. Mavis,et al.  Hysteresis in saturated phospholipid films and its potential relevance for lung surfactant function in vivo. , 1982, Experimental lung research.

[65]  W. Sibbald,et al.  Acute respiratory failure , 1976, Critical care medicine.

[66]  C. Aring,et al.  A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.

[67]  K. Hougaard,et al.  Prediction of acute inhalation toxicity using in vitro lung surfactant inhibition. , 2018, ALTEX.

[68]  L. S. Haug,et al.  Prenatal exposure to perfluoralkyl substances (PFASs) associated with respiratory tract infections but not allergy‐ and asthma‐related health outcomes in childhood , 2018, Environmental research.

[69]  PFOA, ITS SALTS AND PFOA-RELATED COMPOUNDS RISK MANAGEMENT EVALUATION , 2018 .

[70]  A Critical Review of Pharmacokinetic Modelling of PFOS and PFOA to Assist in Establishing HGBVs for these Chemicals , 2017 .

[71]  Yik Ching Lee,et al.  Structure-function relationships in the pulmonary , 2015 .

[72]  J. DeWitt.  Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances , 2015, Molecular and Integrative Toxicology.

[73]  Peder Wolkoff,et al.  Pulmonary toxicity of perfluorinated silane-based nanofilm spray products: solvent dependency. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[74]  Bert van Bavel,et al.  Biotransformation of fluorotelomer compound to perfluorocarboxylates in humans. , 2013, Environment international.

[75]  T. Merritt,et al.  The influence of pH on surface properties of lung surfactants , 2004, Lung.

[76]  G. Petrini,et al.  Pulmonary toxicity following exposure to an aerosolized leather protector. , 1996, Journal of toxicology. Clinical toxicology.